Pharmacological characterization of unique prazosin-binding sites in human kidney

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 368, Issue 1, 2003, Pages 49-56

  Hiraoka, Yasuko ^a   Taniguchi, Takanobu ^a   Tanaka, Takashi ^a   Okada, Kenichiro ^a   Kanamaru, Hiroshi ^a   Muramatsu, Ikunobu ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

1 Adrenoceptor; Human kidney; Human liver; Phentolamine insensitive; Prazosin; Species difference

Indexed keywords

2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; AGMATINE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; AMILORIDE; CORYNANTHINE; DOXAZOSIN; GUANABENZ; GUANFACINE; IODOAZIDOPRAZOSIN I 125; NORADRENALIN; PHENTOLAMINE; PRAZOSIN; PROPRANOLOL; QUINAZOLINE DERIVATIVE; RAUWOLSCINE; TAMSULOSIN; TERAZOSIN; TRIAMTERENE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DRUG ANTAGONISM; ELECTROPHORESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY; LIGAND BINDING; NONHUMAN; PHOTOAFFINITY LABELING; PROTEIN EXPRESSION; RABBIT;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BINDING SITES; HUMANS; KIDNEY; LIVER; MALE; PHOTOAFFINITY LABELS; PRAZOSIN; RABBITS; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, ALPHA-2; SPECIES SPECIFICITY; TRANSFECTION;

EID: 0041659000     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-003-0764-x     Document Type: Article

References (45)

1. Bagamery K, Kovacs L, Viski S, Nyari T, Falkay G (1999) Ontogeny of imidazoline binding sites in the human placenta. Acta Obstet Gynecol Scand 78:89-92
2. 1C-adrenoceptor: studies in the isolated perfused kidney of rat. Br J Pharmacol 115:283-294
3. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
4. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR Jr, Trendelenburg U (1994) IV International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46:121-136
5. 2-sites. Br J Pharmacol 112:1065-1070
6. Clarke D, Garg LC (1991) Alpha-1 adrenergic receptors in renal medullary collecting duct cells. J Pharmacol Exp Ther 259:1081-1087
7. Coupry I, Podevin RA, Dausse JP, Parini A (1987) Evidence for imidazoline binding sites in basolateral membranes from rabbit kidney. Biochem Biophys Res Commun 147:1055-1060
8. Davey M (1987) Mechanism of alpha blockade for blood pressure control. Am J Cardiol 59:18G-28G
9. 2-adrenoceptors. Eur J Pharmacol 361:1-15
10. Flavahan NA, Vanhoutte PM (1986) α-Adrenoceptor subclassification in vascular smooth muscle. Trends Pharmacol Sci 7:347-349
11. 1-adrenoceptor classification. Br J Pharmacol 121:1127-1135
12. 1A-subtype. Eur J Pharmacol 289:81-86
13. 1-Adrenergic receptor subtypes. Molecular structure, function and signaling. Circ Res 78:737-749
14. 1-adrenoceptors: consensus update. Pharmacol Rev 47:267-270
15. Humphreys JE, Waite MA (1989) Alpha-1 blockers. A new generation of antihypertensive agents. J Clin Pharm Ther 14:263-283
16. Kenny B, Ballard S, Blagg J, Fox D (1997) Pharmacological options in the treatment of benign prostatic hyperplasia. J Med Chem 40:1293-1315
17. 2-adrenergic binding sites in basolateral membranes from human kidney. Eur J Pharmacol 206:23-31
18. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
19. Lomasney JW, Cotecchia S, Lefkowitz RJ, Caron MG (1991) Molecular biology of alpha-adrenergic receptors: implications for receptor classification and for structure-function relationships. Biochim Biophys Acta 1095:127-139
20. 2-adrenoceptor subtype function. Trends Pharmacol Sci 18:211-219
21. Mcgrath JC (1982) Evidence for more than one type of postjunctional alpha-adrenoceptor. Biochem Pharmacol 31:467-484
22. Michel MC, Kenny B, Schwinn DA (1995) Classification of alpha-1 adrenoceptor subtypes. Naunyn-Schmiedebergs Arch Pharmacol 352:1-10
23. 2-adrenoceptors in the human kidney. Clin Exp Pharmacol Physiol 20:523-526
24. 1 binding site in rat kidney membranes. Naunyn-Schmiedebergs Arch Pharmacol 365:335-340
25. 1-adrenoceptors in vascular smooth muscle. Br J Pharmacol 99:197-201
26. 1-adrenoceptor subtype-selectivity and comparison with terazosin. Jpn J Pharmacol 78:331-335
27. Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C (1998) Design and synthesis of novel alpha-1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia. J Med Chem 41:5320-5333
28. Parini A, Moudanos CG, Pizzinat N, Lanier SM (1996) The elusive family of imidazoline binding sites. Trends Pharmacol Sci 17:13-16
29. Raddatz R, Lanier SM (1997) Relationship between imidazoline/guanidinium receptive sites and monoamine oxidase A and B. Neurochem Int 30:109-117
30. Raddatz R, Parini A, Lanier SM (1995) Imidazoline/guanidinium binding domains on monoamine oxidases. Relationship to subtypes of imidazoline-binding proteins and tissue-specific interaction of imidazoline ligands with monoamine oxidase B. J Biol Chem 270:27961-27968
31. Regunathan S, Reis DJ (1996) Imidazoline receptors and their endogenous ligands. Annu Rev Pharmacol Toxicol 36:511-544
32. Safa AR (1988) Photoaffinity labeling of the multidrug-resistance-related p-glycoprotein with photoactive analogs of verapamil. Proc Natl Acad Sci USA 85:7187-7191
33. Safa AR, Glover CJ, Swell JL, Meyers MB, Biedler JL, Felsted RL (1987) Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers. J Biol Chem 262:7884-7888
34. 125I]arylazidoprazosin binds to a specific peptide of p-glycoprotein in multidrug-resistance cells. Biochem Biophys Res Commun 166:259-266
35. Schulz A, Hasselblatt A (1988) Phentolamine, a deceptive toll to investigate sympathetic nervous control of insulin release. Naunyn-Schmiedebergs Arch Pharmacol 337:637-643
36. Schulz A, Hasselblatt A (1989) An insulin-releasing property of imidazoline derivatives is not limited to compounds that block α-adrenoceptors. Naunyn-Schmiedebergs Arch Pharmacol 340:321-327
37. 2-adrenoceptors. Br J Pharmacol 128:1215-1222
38. 3H]prazosin in rat, dog and human kidney. J Auton Pharmacol 6:109-116
39. 1-adrenoceptors and human prostates. Life Sci 67:2443-2451
40. 1a-adrenoceptor expressed in Chinese hamster ovary cells. Br J Pharmacol 127:962-968
41. 1-adrenergic receptors of rat heart. J Biol Chem 261:5603-5609
42. 1D-adrenoceptor protein detectable in rat tissues? Naunyn-Schmiedebergs Arch Pharmacol 355:438-446
43. Zhang L, Taniguchi T, Tanaka T, Shinozuka K, Kunitomo M, Nishiyama M, Kamata K, Muramatsu I (2002) Alpha-1 adrenoceptor up-regulation induced by prazosin but not KMD-3213 or reserpine in rats. Br J Pharmacol 135:1757-1764
44. 1-Adrenoceptor subtypes. Eur J Pharmacol 375:261-276
45. Zusman RM (2000) The role of alpha 1-blockers in combination therapy for hypertension. Int J Clin Pract 54:36-40